1-[2,5-dimethyl-3-[(4-methylpiperidin-1-yl)methyl]phenyl]-N-[(2-methyl-1,3-thiazol-4-yl)methyl]methanamine
C21H31N3S — CID 131917300
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2,5-dimethyl-3-[(4-methylpiperidin-1-yl)methyl]phenyl]-N-[(2-methyl-1,3-thiazol-4-yl)methyl]methanamine
1-[2,5-dimethyl-3-[(4-methylpiperidin-1-yl)methyl]phenyl]-N-[(2-methyl-1,3-thiazol-4-yl)methyl]methanamine (PubChem CID 131917300) has the molecular formula C21H31N3S and a molecular weight of 357.57 g/mol. Its IUPAC name is 1-[2,5-dimethyl-3-[(4-methylpiperidin-1-yl)methyl]phenyl]-N-[(2-methyl-1,3-thiazol-4-yl)methyl]methanamine.
Molecular Properties
| Compound Name | 1-[2,5-dimethyl-3-[(4-methylpiperidin-1-yl)methyl]phenyl]-N-[(2-methyl-1,3-thiazol-4-yl)methyl]methanamine |
|---|---|
| PubChem CID | 131917300 |
| Molecular Formula | C21H31N3S |
| Molecular Weight | 357.57 g/mol |
| Exact Mass | 357.22 |
| IUPAC Name | 1-[2,5-dimethyl-3-[(4-methylpiperidin-1-yl)methyl]phenyl]-N-[(2-methyl-1,3-thiazol-4-yl)methyl]methanamine |
| SMILES | Cc1cc(CNCc2csc(C)n2)c(C)c(CN2CCC(C)CC2)c1 |
| InChI | InChI=1S/C21H31N3S/c1-15-5-7-24(8-6-15)13-20-10-16(2)9-19(17(20)3)11-22-12-21-14-25-18(4)23-21/h9-10,14-15,22H,5-8,11-13H2,1-4H3 |
| InChIKey | WMDOJPPRUIKLJF-UHFFFAOYSA-N |
| XLogP | 4.59 |
| TPSA | 28.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 357.57 |
| LogP ≤ 5 | 4.59 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131917300 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.